Z Brener Selected Research

ICI 195739

1/2001	Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres.
7/2000	In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Z Brener Research Topics

Disease

4	Chagas Disease (American Trypanosomiasis) 01/2001 - 01/2000
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2001
1	Rapidly progressive glomerulonephritis with pulmonary hemorrhage 11/2001
1	Vasculitis (Vasculitides) 11/2001
1	Systemic Vasculitis 11/2001
1	Body Weight (Weight, Body) 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

3	TriazolesIBA 01/2001 - 01/2000
2	ICI 195739IBA 01/2001 - 07/2000
2	benzonidazole (benznidazole)IBA 06/2000 - 01/2000
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2001
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2001
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2001
1	poly(lactide) (polylactic acid)IBA 01/2001
1	NitroimidazolesIBA 07/2000
1	Ketoconazole (Nizoral)FDA LinkGeneric 06/2000
1	posaconazole FDA Link 01/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2000

Therapy/Procedure

1	Nanospheres 01/2001
1	Drug Therapy (Chemotherapy) 06/2000